Yu-Feng Tian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yu-Feng Tian has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Cheng-Hsien Lin
Department of Medicine, Mackay Medical College, New Taipei, Taiwan
1 shared publication Chuan-Chih Hsu
Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei 112, Taiwan ; Division of Cardiovascular Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei 112, Taiwan
1 shared publicationLi-Fan Chen
Nursing Department, Cheng Kung University Hospital, Tainan 701, Taiwan ; Department of Nursing, Chang Jung Christian University, Tainan 712, Taiwan
1 shared publicationMao-Tsun Lin
Department of Medical Research, Chi Mei Medical Center, Tainan 710, Taiwan
1 shared publication- Mao-Tsun Lin
Department of Medical Research, Chi Mei Medical Center, Tainan 710, Taiwan
1 shared publication Shu-Fen Hsu
Department of Nursing, Shu-Zen Junior College of Medicine and Management, Kaohsiung 821, Taiwan
1 shared publication
Latest Publications
- Open Access
- 17 February 2014
- Published by Wiley in International Journal of Endocrinology
- Vol. 2014, 1-10
Honokiol Protected against Heatstroke-Induced Oxidative Stress and Inflammation in Diabetic Rats
We aimed at investigating the effect of honokiol on heatstroke in an experimental rat model. Sprogue-Dawley rats were divided into 3 groups: normothermic diabetic rats treated with vehicle solution (NTDR+V), heatstroke-diabetic rats treated with vehicle (HSDR+V), and heatstroke rats treated with konokiol (0.5–5 mg/ml/kg) (HSDR+H). Sixty minutes before the start of heat stress, honokiol or vehicle solution was administered. (HSDR+H) significantly (a) attenuated hyperthermia, hypotension and hypothalamic ischemia, hypoxia, and neuronal apoptosis; (b) reduced the plasma index of the toxic oxidizing radicals; (c) diminished the indices of hepatic and renal dysfunction; (d) attenuated the plasma systemic inflammatory response molecules; (e) promoted plasma levels of an anti-inflammatory cytokine; (f) reduced the index of infiltration of polymorphonuclear neutrophils in the serum; and (g) promoted the survival time fourfold compared with the (HSDR+V) group. In conclusion, honokiol protected against the outcome of heatstroke by reducing inflammation and oxidative stress-mediated multiple organ dysfunction in diabetic rats.
- 17 February 2014
- Published by Wiley in International Journal of Endocrinology
- Vol. 2014, 1-10
Open AccessHonokiol Protected against Heatstroke-Induced Oxidative Stress and Inflammation in Diabetic Rats
We aimed at investigating the effect of honokiol on heatstroke in an experimental rat model. Sprogue-Dawley rats were divided into 3 groups: normothermic diabetic rats treated with vehicle solution (NTDR+V), heatstroke-diabetic rats treated with vehicle (HSDR+V), and heatstroke rats treated with konokiol (0.5–5 mg/ml/kg) (HSDR+H). Sixty minutes before the start of heat stress, honokiol or vehicle solution was administered. (HSDR+H) significantly (a) attenuated hyperthermia, hypotension and hypothalamic ischemia, hypoxia, and neuronal apoptosis; (b) reduced the plasma index of the toxic oxidizing radicals; (c) diminished the indices of hepatic and renal dysfunction; (d) attenuated the plasma systemic inflammatory response molecules; (e) promoted plasma levels of an anti-inflammatory cytokine; (f) reduced the index of infiltration of polymorphonuclear neutrophils in the serum; and (g) promoted the survival time fourfold compared with the (HSDR+V) group. In conclusion, honokiol protected against the outcome of heatstroke by reducing inflammation and oxidative stress-mediated multiple organ dysfunction in diabetic rats.
- Open Access
- 1 January 2013
- Published by Wiley in Mediators of Inflammation
- Vol. 2013, 1-8
Melatonin Improves Outcomes of Heatstroke in Mice by Reducing Brain Inflammation and Oxidative Damage and Multiple Organ Dysfunction
We report here that when untreated mice underwent heat stress, they displayed thermoregulatory deficit (e.g., animals display hypothermia during room temperature exposure), brain (or hypothalamic) inflammation, ischemia, oxidative damage, hypothalamic-pituitary-adrenal axis impairment (e.g., decreased plasma levels of both adrenocorticotrophic hormone and corticosterone during heat stress), multiple organ dysfunction or failure, and lethality. Melatonin therapy significantly reduced the thermoregulatory deficit, brain inflammation, ischemia, oxidative damage, hypothalamic-pituitary-adrenal axis impairment, multiple organ dysfunction, and lethality caused by heat stroke. Our data indicate that melatonin may improve outcomes of heat stroke by reducing brain inflammation, oxidative damage, and multiple organ dysfunction.
- 1 January 2013
- Published by Wiley in Mediators of Inflammation
- Vol. 2013, 1-8
Open AccessMelatonin Improves Outcomes of Heatstroke in Mice by Reducing Brain Inflammation and Oxidative Damage and Multiple Organ Dysfunction
We report here that when untreated mice underwent heat stress, they displayed thermoregulatory deficit (e.g., animals display hypothermia during room temperature exposure), brain (or hypothalamic) inflammation, ischemia, oxidative damage, hypothalamic-pituitary-adrenal axis impairment (e.g., decreased plasma levels of both adrenocorticotrophic hormone and corticosterone during heat stress), multiple organ dysfunction or failure, and lethality. Melatonin therapy significantly reduced the thermoregulatory deficit, brain inflammation, ischemia, oxidative damage, hypothalamic-pituitary-adrenal axis impairment, multiple organ dysfunction, and lethality caused by heat stroke. Our data indicate that melatonin may improve outcomes of heat stroke by reducing brain inflammation, oxidative damage, and multiple organ dysfunction.